Patents by Inventor Philippe Glaser
Philippe Glaser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11592360Abstract: A method for testing a technical system. Tests are carried out with the aid of a simulation of the system. The tests are evaluated with respect to a fulfillment measure of a quantitative requirement on the system and different error measures of the simulation. On the basis of the fulfillment measure and each of the error measures, a classification of the tests is carried out as either reliable or unreliable case by case. A selection among the error measures is made on the basis of a number of the tests classified as reliable.Type: GrantFiled: March 8, 2021Date of Patent: February 28, 2023Assignee: Robert Bosch GmbHInventors: Christoph Gladisch, Ji Su Yoon, Joachim Sohns, Philipp Glaser, Thomas Heinz, Daniel Seiler-Thull
-
Publication number: 20220092237Abstract: A computer-implemented method for processing data associated with a simulation model, the simulation model being designed to simulate at least one aspect of a technical system. The method includes: ascertaining a first parameter group of parameters of the simulation model, whose sensitivity exceeds a predefinable sensitivity limiting value, ascertaining a substitute model for the simulation model based on the first parameter group, assessing a quality of the substitute model, a quality measure characterizing the quality of the substitute model being obtained.Type: ApplicationFiled: September 17, 2021Publication date: March 24, 2022Inventors: Antoine Vandamme, Michael Schick, Philipp Glaser, Wolfgang Ulmer
-
Patent number: 11243858Abstract: A method for testing a technical system. The method includes: tests are carried out with the aid of a simulation of the system, the tests are evaluated with respect to a fulfillment measure of a quantitative requirement on the system and an error measure of the simulation, on the basis of the fulfillment measure and error measure, a classification of the tests as either reliable or unreliable is carried out.Type: GrantFiled: March 10, 2021Date of Patent: February 8, 2022Assignee: Robert Bosch GmbHInventors: Christoph Gladisch, Daniel Seiler-Thull, Joachim Sohns, Philipp Glaser, Thomas Heinz, Ji Su Yoon
-
Patent number: 11237931Abstract: A method for testing a technical system. The method includes: tests are carried out with the aid of a simulation of the system, the tests are evaluated with respect to a fulfillment measure of a quantitative requirement on the system and an error measure of the simulation, on the basis of the fulfillment measure and error measure, a classification of the tests as either reliable or unreliable is carried out, and a test database is improved on the basis of the classification.Type: GrantFiled: March 9, 2021Date of Patent: February 1, 2022Assignee: Robert Bosch GmbHInventors: Christoph Gladisch, Daniel Seiler-Thull, Ji Su Yoon, Philipp Glaser, Thomas Heinz, Joachim Sohns
-
Publication number: 20210364393Abstract: A method for testing a technical system. Tests are carried out with the aid of a simulation of the system. The tests are evaluated with respect to a fulfillment measure of a quantitative requirement on the system and different error measures of the simulation. On the basis of the fulfillment measure and each of the error measures, a classification of the tests is carried out as either reliable or unreliable case by case. A selection among the error measures is made on the basis of a number of the tests classified as reliable.Type: ApplicationFiled: March 8, 2021Publication date: November 25, 2021Inventors: Christoph Gladisch, Ji Su Yoon, Joachim Sohns, Philipp Glaser, Thomas Heinz, Daniel Seiler-Thull
-
Publication number: 20210342239Abstract: A method for testing a technical system. The method includes: tests are carried out with the aid of a simulation of the system, the tests are evaluated with respect to a fulfillment measure of a quantitative requirement on the system and an error measure of the simulation, on the basis of the fulfillment measure and error measure, a classification of the tests as either reliable or unreliable is carried out.Type: ApplicationFiled: March 10, 2021Publication date: November 4, 2021Inventors: Christoph Gladisch, Daniel Seiler-Thull, Joachim Sohns, Philipp Glaser, Thomas Heinz, Ji Su Yoon
-
Publication number: 20210342238Abstract: A method for testing a technical system. The method includes: tests are carried out with the aid of a simulation of the system, the tests are evaluated with respect to a fulfillment measure of a quantitative requirement on the system and an error measure of the simulation, on the basis of the fulfillment measure and error measure, a classification of the tests as either reliable or unreliable is carried out, and a test database is improved on the basis of the classification.Type: ApplicationFiled: March 9, 2021Publication date: November 4, 2021Inventors: Christoph Gladisch, Daniel Seiler-Thull, Ji Su Yoon, Philipp Glaser, Thomas Heinz, Joachim Sohns
-
Patent number: 9874560Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by said polynucleotides, as well as to antibodies directed or raised against said polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.Type: GrantFiled: October 12, 2016Date of Patent: January 23, 2018Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS DESCARTES, ASSISTANCE PUBLIQUE-HOPITAUX DE PARISInventors: Claire Poyart, Marie-Cecile Lamy, Shaynoor Dramsi, Elisabeth Sauvage, Philippe Glaser, Patrick Trieu-Cuot
-
Publication number: 20170052181Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by said polynucleotides, as well as to antibodies directed or raised against said polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.Type: ApplicationFiled: October 12, 2016Publication date: February 23, 2017Applicants: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS DESCARTES, ASSISTANCE PUBLIQUE - HOPITAUX DE PARISInventors: Claire POYART, Marie-Cecile LAMY, Shaynoor DRAMSI, Elisabeth SAUVAGE, Philippe GLASER, Patrick TRIEU-CUOT
-
Patent number: 9551039Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by said polynucleotides, as well as to antibodies directed or raised against said polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.Type: GrantFiled: April 16, 2014Date of Patent: January 24, 2017Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS DESCARTES, ASSISTANCE PUBLIQUE—HOPITAUX DE PARISInventors: Claire Poyart, Marie-Cecile Lamy, Shaynoor Dramsi, Elisabeth Sauvage, Philippe Glaser, Patrick Trieu-Cuot
-
Publication number: 20140302498Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by said polynucleotides, as well as to antibodies directed or raised against said polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.Type: ApplicationFiled: April 16, 2014Publication date: October 9, 2014Applicants: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS DESCARTES, ASSISTANCE PUBLIQUE - HOPITAUX DE PARISInventors: Claire POYART, Marie-Cecile LAMY, Shaynoor DRAMSI, Elisabeth SAUVAGE, Philippe GLASER, Patrick TRIEU-CUOT
-
Patent number: 8735565Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by the polynucleotides, as well as to antibodies directed or raised against the polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.Type: GrantFiled: December 20, 2006Date of Patent: May 27, 2014Assignees: Institut Pasteur, Centre National de la Recherche Scientifique, Universite Paris Descartes, Assistance Publique-Hospitaux de ParisInventors: Claire Poyart, Marie-Cecile Lamy, Shaynoor Dramsi, Elisabeth Couve, Philippe Glaser, Patrick Trieu-Cuot
-
Publication number: 20090162847Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by said polynucleotides, as well as to antibodies directed or raised against said polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.Type: ApplicationFiled: December 20, 2006Publication date: June 25, 2009Applicants: INSTITUT PASTEUR, UNIVERSITE RENE DESCARTES (PARIS V), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Claire Poyart, Marie-Cecile Lamy, Shaynoor Dramsi, Elisabeth Couve, Philippe Glaser, Patrick Trieu-Cuot
-
Publication number: 20070020625Abstract: The present invention relates to the genomic sequence and to nucleotide sequences encoding polypeptides of Photorhabdus luminescens. The present invention further relates to polypeptides involved in operons involved in the biosynthesis of antibiotics or toxins, as well as polypeptides with activity of the antibiotic or toxin. Uses of the aforementioned polypeptides in pesticides, bactericides, or fungicides is provides. In addition, the present invention provides vectors, cells, or animals containing the sequences of the present invention.Type: ApplicationFiled: February 7, 2002Publication date: January 25, 2007Inventors: Eric Duchaud, Sead Taourit, Philippe Glaser, Lionel Frangeul, Frederik Kunst, Antoine Danchin, Carmen Buchrieser
-
Publication number: 20060257894Abstract: This invention provides 163 genes that are unique to the L. monocytogenes serovar 4b strain, CLIP80459, compared with L. monocytogenes EGDe strain. These genes are the basis for isolated nucleic acids, hybridization supports, and kits comprising a nucleotide sequence that is unique to a serovar 4b strain of L. monocytogenes. The invention also provides methods for identifying a L. monocytogenes in a sample, methods for identifying the lineage of a L. monocytogenes in a sample, and methods for sub-lineage typing of a L. monocytogenes in a sample. The invention also provides hybridization supports comprising a L. monocytogenes lineage-specific nucleic acid sequence, hybridization supports comprising a L. monocytogenes sub-lineage-specific nucleic acid sequence combination, and kits comprising a nucleic acid or hybridization support of the invention. Additionally, the invention provides specific macroarrays, methods, and kits for use in serotyping L. monocytogenes.Type: ApplicationFiled: February 21, 2006Publication date: November 16, 2006Inventors: Michel Doumith, Carmen Buchrieser, Philippe Glaser, Paul Martin, Christine Jacquet, Patricia Garrido, Christophe Rusniok, Frederik Kunst
-
Publication number: 20060078901Abstract: The genome sequence and nucleotide sequences of Listeria monocytogenes EGD-e are provided. Polypeptide sequences, including surface or cell envelope polypeptides, and polypeptides involved in metabolism, including B12 biosynthesis, are also provided. Uses of these sequences are also provided.Type: ApplicationFiled: January 28, 2005Publication date: April 13, 2006Inventors: Carmen Buchrieser, Lionel Frangeul, Elisabeth Couve, Christophe Rusniok, Hafida Fsihi, Pierre Dehoux, Olivier Dussurget, Farid Chetouani, Hafed Nedjari, Philippe Glaser, Franck Kunst, Pascale Cossart, Justin Daniels, Werner Goebei, Jurgen Kreft, Michael Kuhn, Eva Ng, Jose Vazquez-Boland, Gustavo Dominguez-Bernal, Patricia Garrido-Garcia, Alberto Tierrez-Martinez, Alexandra Amend, Trinad Chakraborty, Eugen Domann, Thorsten Hain, Patrick Berche, Alain Charbit, Lionel Durant, Jose-Claudio Perez-Diaz, Fernando Baquero, Francisco Garcia Del Portillo, Nuria Gomez-Lopez, Encarna Maduenio, Betriz de Pablos, Jurgen Wehland, Uwe Karst, Karl-Dieter Entian, Jorg Hauf, Matthias Rose, Hamut Voss
-
Publication number: 20040018514Abstract: The invention concerns a nucleotide sequence derived from Listeria inocua corresponding to a sequence selected among SEQ ID NO: 1 to SEQ ID NO: 11 and the comparative analysis of said genome with that of Listeria monocytogenes.Type: ApplicationFiled: July 10, 2003Publication date: January 29, 2004Inventors: Frederik Kunst, Philippe Glaser
-
Patent number: 5183745Abstract: The adenyl cyclase derivatives are atoxic derivatives in which one or several amino acids are different from those present in the toxic protein, the antibodies formed against these derivatives recognize, however, the toxic protein. These derivatives can be used as vaccines.Type: GrantFiled: October 25, 1989Date of Patent: February 2, 1993Assignee: Institut PasteurInventors: Antoine Danchin, Philippe Glaser, Evelyne Krin, Octavien Barzu, Daniel Ladant, Agnes Ullmann